Following approval at the December 2025 NENC Clinical Effectiveness and Governance (CEG) Subcommittee the following guidelines have now been published on the NTAG website:
- NENC Shared Care Protocol – NENC Shared Care Protocol – Methotrexate (oral and subcutaneous) for patients in adult services (excluding cancer care) https://ntag.nhs.uk/shared-care-guidelines/
Please note there are no changes to the current prescribing, supply and monitoring arrangements for subcutaneous methotrexate across NENC.